Customer Reviews

  • \"Redoxis has been a valuable collaborator in our studies. Their expertise, reliability and effective study execution are an asset!\"

    Sushrusha Nayak, Manager Preclinical

    Chiesi

  • \"We worked with Redoxis for AAV injections in a preclinical setting and were very impressed with their expertise, reliability, and communication throughout the project. We were extremely satisfied with the results and would gladly recommend their services.\"

    Marcus Davidsson, Chief Excecutive Officer

    rAAVen Therapeutics, Lund, Sweden

  • \"Redoxis provided us with state-of-the-art in vivo models, which we utilized to assess the efficacy and pharmacokinetics of our small molecule compounds. Their team delivered highly robust and reproducible data, which proved to be a critical component in advancing our early-stage drug development program.\"

    Irene Knussel, Chief Scientific Officer

    Rewind Therapeutics

  • \"The report from Redoxis is an example of a good report\"

    Lars Hornum, Senior Principal Scientist

    LEO Pharma

  • \"BCI collaborates with Redoxis for many years and we really appreciate study discussions, planning, flexibility and study reports. Redoxis is a really competitive and expert CRO for in-vivo and in-vitro studies and with the sense of urgency. I really recommend to use their platform and expertise.\"

    Dominique Surleraux, President and CEO

    BCI Pharma

  • \"Redoxis is a much-appreciated partner for preclinical efficacy evaluation of our candidate drug in rodents, always professional and ready to interact and share their expertise with great commitment.\"

    Susanne Lindquist

    CSO Lipum AB

  • \"We highly appreciate the scientific expertise and problem solving skills combined with flexibility and service commitment shown by the Redoxis team. We are very satisfied with the studies performed both in vitro and in vivo and look forward to continued and extended collaborations.\"

    Susanna Dahlgren, Senior Director Project Management

    Aqilion AB

  • \"A very professional team. We are very satisfied with the performance of our studies contracted to Redoxis.\"

    Jan Alenfall, CEO

    Follicum, Lund, Sweden

  • \"Top professional performance – would always work with Redoxis again\"

    Thomas Mehrling, Managing Director

    EDO GmbH, Germany

  • \"Redoxis Research Team is excellent, professional and extremely responsible team that can support your research at any point along the drug discovery process.\"

    Ravil A. Khamitov, General Director

    IBC Generium LLC, Russia

  • \"It was a real pleasure to communi­cate with Redoxis team and the performed studies fit very well to our expectancies. In other words, we are fully satisfied.\"

    Sebastian Hannedouche

    Euroscreen, Belgium

  • \"I will like to place on record the very professional preparation of the protocol , conduct and preparation of the study report to our satisfaction.\"

    Sunil Bhakaran, Managing Director

    Indus Biotech, India

  • \"I will like to place on record the very professional preparation of the protocol , conduct and preparation of the study report to our satisfaction.\"

    Bo Åkerström, Founder

    A1M Pharma, Sweden

  • \"It has been a real pleasure to collaborate with Redoxis, a CRO that we have the greatest confidence in. Swift planning of projects, starts of experiments with a minimum of delay, very professional staff and thus high standard studies and rapid and excellent reports are important elements in the development of this good relation.\"

    Erik Walum, CEO

    Glucox Biotech, Sweden

  • \"For ease and excellence\"

    Lars Pettersson, CEO

    LP Pharma, Sweden

  • \"Professional services with customer focus.\"

    Eskil Söderlind

    Merozyne, Sweden

  • \"A professional company with personal touch.\"

    Thomas Bäckström

    BTB Pharma, Sweden